Sign In
Buy FMS
$25.66
-0.0400 (-0.156%)
At Close: Jul 31, 2026
Fresenius Medical Care: Heads Don't Roll - They Run
08:30am, Thursday, 27'th Jul 2023
Fresenius Medical Care is the world's leading full-service provider of dialysis care and benefits from the entire value chain thanks to its vertical integration. Despite its market-leading position, F
Why Shares of Fresenius Medical Jumped This Week
02:32pm, Friday, 14'th Jul 2023
The move is meant to allow better and timelier decision-making. Fresenius operates dialysis facilities across the world.
Fresenius Medical shareholders approve change in legal form
09:54am, Friday, 14'th Jul 2023
Fresenius Medical Care said on Friday that shareholders voted with a 99.88% majority in favour of a change that will simplify its governance and make parent Fresenius SE a regular minority shareholder
Fresenius Medical Care shares drop on U.S. dialysis payment adjustment
03:27am, Tuesday, 27'th Jun 2023
Shares in kidney dialysis group Fresenius Medical Care declined 1.7% at market open in Germany on Tuesday after a payment increase proposed by a major U.S. public health insurance body fell short of m
Fresenius Medical Care: Other Stocks Still Better, But Upside Exists
12:41pm, Thursday, 01'st Jun 2023
Fresenius Medical Care has shown some improvement in recent trends, but still faces headwinds and pressures in its markets. Analysts have consistently underestimated FMS's performance, and I think the
Fresenius Medical (FMS) Q1 Earnings and Revenues Beat Estimates
12:55pm, Wednesday, 10'th May 2023
Fresenius Medical's (FMS) first-quarter revenues benefit from strong performances across all segments, especially the North America and Asia-Pacific regions. However, rising costs hurt margins.
Fresenius Medical's (FMS) Q4 Earnings and Revenues Beat
02:45pm, Thursday, 23'rd Feb 2023 Zacks Investment Research
Fresenius Medical's (FMS) fourth-quarter revenues benefit from strong performance across all segments, especially in the North America and Asia-Pacific regions. However, rising costs hurt margins.
eBay, Unity Software, Teladoc Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
10:53am, Thursday, 23'rd Feb 2023 Benzinga
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
American Well Corporation (NYSE: AMWL) shares fell 10.8% to $3.23 in
Francisco Garcia Parames' Cobas Funds 4th-Quater Letter
06:01pm, Wednesday, 22'nd Feb 2023
Dear Investor:
Fresenius Medical Care AG & Co. KGaA (FMS) Q4 2022 Earnings Call Transcript
12:37pm, Wednesday, 22'nd Feb 2023
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS ) Q4 2022 Earnings Conference Call February 22, 2023 9:30 AM ET Company Participants Dominik Heger - Head, Investor Relations Helen Giza - Chair & Chief
MedTech Stocks' Q4 Earnings on Feb 22: FMS, GKOS & More
03:06pm, Tuesday, 21'st Feb 2023 Zacks Investment Research
MedTech companies' Q4 results are likely to reflect strength in customer demand. Let's see how FMS, GKOS, MMSI and DVA are placed ahead of their earnings releases.
Competition Coming For AbbVie's Blockbuster Humira
01:08am, Thursday, 16'th Feb 2023
It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.
Fresenius: The Company Is Climbing, And I'm At 'Buy'
07:53am, Friday, 06'th Jan 2023
I've been unfailingly bullish in the long-term on Fresenius - both the medical care, but also the main company headquartered in Germany. Fresenius has had an extremely tricky set of years, due to comp
The 9 Best 4+% Yielding Dividend Aristocrats For 2023
12:50pm, Saturday, 31'st Dec 2022 Seeking Alpha
There are no more dependable dividend growth blue-chips for the 2023 recession than dividends aristocrats. Click to read about my favorite 9 dividend stocks.
The 9 Best 4+% Yielding Dividend Aristocrats For 2023
07:50am, Saturday, 31'st Dec 2022
Dividend growth blue-chips are the best performing assets in history. There are no more dependable dividend growth blue-chips for the 2023 recession than dividends aristocrats.
